BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,677 | +0.7% | 1,120 | 0.0% | 0.06% | +3.4% |
| Q2 2023 | $120,882 | -17.6% | 1,120 | -4.8% | 0.06% | -24.4% |
| Q1 2023 | $146,619 | -18.3% | 1,177 | -1.5% | 0.08% | -25.0% |
| Q4 2022 | $179,513 | +3.8% | 1,195 | -7.0% | 0.10% | +2.0% |
| Q3 2022 | $173,000 | -21.4% | 1,285 | -13.0% | 0.10% | -25.5% |
| Q2 2022 | $220,000 | -15.7% | 1,477 | -3.5% | 0.14% | +7.0% |
| Q1 2022 | $261,000 | -37.6% | 1,531 | -5.7% | 0.13% | -35.0% |
| Q4 2021 | $418,000 | -5.6% | 1,623 | 0.0% | 0.20% | -28.9% |
| Q3 2021 | $443,000 | -35.6% | 1,623 | -47.2% | 0.28% | -34.4% |
| Q2 2021 | $688,000 | +130.1% | 3,071 | +12.2% | 0.42% | +91.8% |
| Q1 2021 | $299,000 | +27.8% | 2,737 | -4.5% | 0.22% | +14.0% |
| Q4 2020 | $234,000 | – | 2,865 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |